top of page
Rechercher


Florian Naudet
2 févr. 20231 min de lecture
A training curriculum for clinical trial data sharing
Data sharing is a complex endeavor that maximizes the value of clinical research. In a recent piece, we argue that more biomedical...
48 vues
0 commentaire


Florian Naudet
13 déc. 20222 min de lecture
"There’s nothing in headache medicine that can really do that" Really?
With a group of independent experts, we were very surprised to see that the scientific journal Nature published a series of 12 news...
60 vues
0 commentaire


Florian Naudet
20 sept. 20224 min de lecture
Exploring Vibration of Effects in Pooled Analyses
Pooled analyses (ie, non-exhaustive quantitative syntheses that pool individual participant data from several independent RCTs exploring...
41 vues
0 commentaire


Florian Naudet
24 mai 20224 min de lecture
Feedback on the process of our first registered report
"Registered Reports is a publishing format that emphasizes the importance of the research question and the quality of methodology by...
42 vues
0 commentaire


Florian Naudet
21 mai 20223 min de lecture
Data-sharing and re-analysis for main studies assessed by the EMA: our first registered report!
We have just published our first registered report in BMC Medicine. Let's celebrate ! Transparency and reproducibility are expected to be...
151 vues
0 commentaire


Florian Naudet
15 nov. 20211 min de lecture
Registered report / in principle acceptance: esketamine for “treatment resistant depression"
Our new registered report "Efficacy and safety of esketamine for “treatment resistant depression”: registered report for a Systematic...
180 vues
0 commentaire


Florian Naudet
22 août 20212 min de lecture
Studying the impact of data sharing initiatives
In our new scoping review, we explored the impact of clinical trial data-sharing initiatives. We looked at various outcome domains...
53 vues
0 commentaire


Florian Naudet
9 août 20212 min de lecture
An open science pathway for drug marketing authorization
Our essay "An open science pathway for drug marketing authorization -Registered drug approval" won the "Reimagine Biomedical Research for...
33 vues
0 commentaire


Florian Naudet
25 mai 20213 min de lecture
Concerns about the Sputnik V phase 3 trial
In a recent letter, as part of an international group (Enrico Bucci, Johannes Berkhof, André Gillibert, Gowri Gopalakrishna, Raffaele A...
987 vues
0 commentaire


Florian Naudet
30 avr. 20211 min de lecture
Sharing of Clinical Trial Data - 2nd Workshop - Recordings
On April 1st, 2021, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of Medicine) organized a workshop...
72 vues
0 commentaire


Florian Naudet
27 mars 20215 min de lecture
Conflicts of interests in research
We have just registered our new protocol on the Open Science Framework. We are planning a new study about conflict of interests in...
111 vues
0 commentaire


Florian Naudet
24 mars 20212 min de lecture
Sharing of Clinical Trial Data - 2nd Workshop 1.04.2021
Again some good news! On April the 1st this year, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of...
226 vues
0 commentaire


Florian Naudet
7 janv. 20211 min de lecture
Sharing of Clinical Trial Data - Workshop 19.01.2021
Finally some good news in 2021 ! On January 19th this year, our group and colleagues from the Ludwig-Maximilians-Universität München...
246 vues
0 commentaire


fabiola gaba
20 août 20201 min de lecture
Funders' data sharing policies in therapeutic research
“Funders’ data-sharing policies in therapeutic research: a survey of commercial and non-commercial funders” is the new article, from the...
54 vues
0 commentaire


Florian Naudet
7 août 20203 min de lecture
Artemisia infusions: correcting the records was difficult
This story is about Artemisia and two very "interesting" (or should I say infamous) studies. 1/ Well, read this paper: "Artemisia annua...
785 vues
0 commentaire


Florian Naudet
25 juin 202014 min de lecture
Proposal for improved reporting of the RECOVERY trial
Taking advantage of the many good things pre print servers offer, and in a spirit of open science, we wrote a peer review with Andre...
169 vues
0 commentaire


Max
31 mai 20201 min de lecture
An Audit of journals following the ICMJE recommendations
"Data-sharing recommendations in biomedical journals and Randomized Controlled Trials: an audit of journals following the ICMJE...
47 vues
0 commentaire


Florian Naudet
5 mai 20204 min de lecture
The BACLOVILLE study and the long road to transparency
We hypothesize in our projects that re-analyses of a random sample of unselected Randomised Controlled Trials will result in a good...
98 vues
0 commentaire


Max
10 avr. 20202 min de lecture
ReiTheR goes Berlin
In mid-february our team made its way to the 3 day REWARD EQUATOR conference, which was hosted by the BIH Quest Center in Berlin,...
56 vues
0 commentaire


Florian Naudet
8 avr. 20201 min de lecture
EMA monitor
Our new paper, "The evidence base for psychotropic drugs approved by the European Medicines Agency [EMA]: a meta-assessment of all...
80 vues
0 commentaire
Blog: Blog2
bottom of page